Skip to content
Triangle logo TriangleGet started
← Back to this collection

PUBLICATIONS · 24882434

Olaparib maintenance therapy in patients with platinum-sensitive relapsed serous ovarian cancer: a preplanned retrospective analysis of outcomes by BRCA status in a randomised phase 2 trial.

Open original source → · Download preserved record

Bibliographic metadata only. No full-text article or abstract is reproduced. Absence of a captured notice is not confirmation that a publication is clear of corrections or retractions.

Journal
Lancet Oncol
Publication date
2014 Jul
First author
Ledermann J

This record carries publication-notice metadata. Review the notices below before relying on it.

Publication notices

absence is not clearance
true
has correction metadata
true
has expression of concern metadata
false
has retraction in link
false
pubmed marks article retracted
false
pubmed marks retraction notice
false
relationships
  1. citation
    Lancet Oncol. 2014 Jul;15(8):783-5. doi: 10.1016/S1470-2045(14)70246-3.
    note
    Source null
    related pmid
    24882435
    relationship
    Comment in
  2. citation
    Lancet Oncol. 2015 Apr;16(4):e158. doi: 10.1016/S1470-2045(15)70153-1.
    note
    Source null
    related pmid
    25846095
    relationship
    Erratum in

Authors and identifiers

  1. name
    Ledermann J
    type
    Author
  2. name
    Harter P
    type
    Author
  3. name
    Gourley C
    type
    Author
  4. name
    Friedlander M
    type
    Author
  5. name
    Vergote I
    type
    Author
  6. name
    Rustin G
    type
    Author
  7. name
    Scott CL
    type
    Author
  8. name
    Meier W
    type
    Author
  9. name
    Shapira-Frommer R
    type
    Author
  10. name
    Safra T
    type
    Author
  11. name
    Matei D
    type
    Author
  12. name
    Fielding A
    type
    Author
Complete bibliographic record and source provenance
authors
  1. name
    Ledermann J
    type
    Author
  2. name
    Harter P
    type
    Author
  3. name
    Gourley C
    type
    Author
  4. name
    Friedlander M
    type
    Author
  5. name
    Vergote I
    type
    Author
  6. name
    Rustin G
    type
    Author
  7. name
    Scott CL
    type
    Author
  8. name
    Meier W
    type
    Author
  9. name
    Shapira-Frommer R
    type
    Author
  10. name
    Safra T
    type
    Author
  11. name
    Matei D
    type
    Author
  12. name
    Fielding A
    type
    Author
bibliography ids
  1. nci-bib-d231c75b9c70406ba5aacc3f
book metadata
content sha256
e9f076b7660b35394b7958935b9f04714e893f91c125689fd664f1c9dbbfd411
document type
citation
dois
  1. 10.1016/S1470-2045(14)70228-1
electronic publication date
display
2014 May 31
precision
day
year
2014
evidence scope
bibliographic_metadata_only
id
pubmed:24882434
immutable id
pubmed:24882434@e9f076b7660b35394b7958935b9f04714e893f91c125689fd664f1c9dbbfd411
journal
abbreviation
Lancet Oncol
issn electronic
1474-5488
issn print
1470-2045
issue
8
name
The Lancet. Oncology
nlm unique id
100957246
pages
852-61
volume
15
languages
  1. eng
notices
absence is not clearance
true
has correction metadata
true
has expression of concern metadata
false
has retraction in link
false
pubmed marks article retracted
false
pubmed marks retraction notice
false
relationships
  1. citation
    Lancet Oncol. 2014 Jul;15(8):783-5. doi: 10.1016/S1470-2045(14)70246-3.
    note
    Source null
    related pmid
    24882435
    relationship
    Comment in
  2. citation
    Lancet Oncol. 2015 Apr;16(4):e158. doi: 10.1016/S1470-2045(15)70153-1.
    note
    Source null
    related pmid
    25846095
    relationship
    Erratum in
outcomes validated
false
pmid
24882434
provenance
batch id
063b6c38419f18d4021f
provider
NCBI PubMed ESummary
record sha256
706430ece4f867cdc293eb6816885e9c57f20e06cb5529be60d4f0f2cacec338
response sha256
5abcae41e9384a85f92695ef76b244ffd933f07a58a51082c160af8743d196ad
retrieved at
2026-09-09T23:47:02.607425+00:00
publication date
display
2014 Jul
precision
month
year
2014
publication types
  1. Clinical Trial, Phase II
  2. Journal Article
  3. Randomized Controlled Trial
  4. Research Support, Non-U.S. Gov't
record status
PubMed - indexed for MEDLINE
schema version
1.0
source url
https://pubmed.ncbi.nlm.nih.gov/24882434/
title
Olaparib maintenance therapy in patients with platinum-sensitive relapsed serous ovarian cancer: a preplanned retrospective analysis of outcomes by BRCA status in a randomised phase 2 trial.

Preserved source evidence · Not medical advice